AOD-9604 Research Protocols & Administration Dosing in Published Research Research investigations have employed diverse AOD-9604 doses across species and administration routes: Rodent studies: 250-500 mcg/kg orally or intraperitoneally was most common for obesity research Rabbit models: 0.25 mg per joint for osteoarthritis studies (intra-articular injection) Pig pharmacokinetic studies: 1.5 mg/kg IV and 2 mg/kg oral for metabolism characterization Human clinical trials: Oral doses of 0.25-10 mg daily
I., Hirshman M
Copper peptides degrade rapidly at room temperature studies using HPLC tracking found potency drops to 7075% at 14 days refrigerated and below 60% at 21 days
Cecal samples were collected at euthanization, then flash-frozen and stored at 80 C
Wool may offer an option for those struggling with weight issues and stalled fitness goals
People notice a reduction in stored fat, faster metabolism, improved fat burning, higher energy levels, enhanced gallbladder, and liver function, lean body mass preservation, liver detoxification, enhanced nutrient absorption, and increased mental clarity